The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
ATC Classification
L02BX03 - abiraterone ; Belongs to the class of other hormone antagonists and related agents. Used in the treatment of metastatic castration-resistant prostate cancer.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.